Polysaccharide antigens of Pseudomonas aeruginosa
- PMID: 1698385
- DOI: 10.3109/10408419009105729
Polysaccharide antigens of Pseudomonas aeruginosa
Abstract
The major polysaccharide antigens of P. aeruginosa are the cell-wall lipopolysaccharides many of which have an acidic polysaccharide chain (O-antigen) rich in unusual amino sugars. The D-rhamnose-rich polysaccharide antigen common to many serologically distinct strains is also associated with the lipopolysaccharide. The high-molecular-weight polysaccharides with O-specificity are present in extracellular slime produced by strains isolated from the environmental and from the immunocompromised hosts. The extracellular antigenic polysaccharide of another type (bacterial alginate) is expressed by mucoid strains isolated from patients with cystic fibrosis. Serotype-specific immune responses after infection are directed at the lipopolysaccharides and these heat-stable antigens serve as the basis for differentiation of P. aeruginosa strains. Both the cell-wall antigens including conjugates of the O-polysaccharides with different proteins and the extracellular antigens have been used to prepare specific antibodies tested for protection against infections due to P. aeruginosa.
Similar articles
-
Pseudomonas aeruginosa antigens as potential vaccines.FEMS Microbiol Rev. 1997 Nov;21(3):243-77. doi: 10.1111/j.1574-6976.1997.tb00353.x. FEMS Microbiol Rev. 1997. PMID: 9451816 Review.
-
[Antigenic polysaccharides of bacteria. 21. The structure of O-specific polysaccharide chains and serological specificity of lipopolysaccharides from 7 Pseudomonas aeruginosa immunotypes].Bioorg Khim. 1987 Jan;13(1):88-96. Bioorg Khim. 1987. PMID: 2436629 Russian.
-
Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey).J Hyg Epidemiol Microbiol Immunol. 1982;26(4):417-27. J Hyg Epidemiol Microbiol Immunol. 1982. PMID: 6819316
-
Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).Infect Immun. 1995 Jan;63(1):21-6. doi: 10.1128/iai.63.1.21-26.1995. Infect Immun. 1995. PMID: 7528730 Free PMC article.
-
Antibodies to lipopolysaccharides: some diagnostic and protective aspects.APMIS Suppl. 1990;18:1-38. APMIS Suppl. 1990. PMID: 2122911 Review. No abstract available.
Cited by
-
Flagellin glycans from two pathovars of Pseudomonas syringae contain rhamnose in D and L configurations in different ratios and modified 4-amino-4,6-dideoxyglucose.J Bacteriol. 2007 Oct;189(19):6945-56. doi: 10.1128/JB.00500-07. Epub 2007 Jul 20. J Bacteriol. 2007. PMID: 17644592 Free PMC article.
-
The UDP-GalNAcA biosynthesis genes gna-gne2 are required to maintain cell envelope integrity and in vivo fitness in multi-drug resistant Acinetobacter baumannii.Mol Microbiol. 2020 Jan;113(1):153-172. doi: 10.1111/mmi.14407. Epub 2019 Nov 19. Mol Microbiol. 2020. PMID: 31680352 Free PMC article.
-
Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.Int J Med Microbiol. 2007 Sep;297(5):277-95. doi: 10.1016/j.ijmm.2007.03.012. Epub 2007 Apr 27. Int J Med Microbiol. 2007. PMID: 17466590 Free PMC article. Review.
-
Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa.Front Immunol. 2019 Apr 24;10:781. doi: 10.3389/fimmu.2019.00781. eCollection 2019. Front Immunol. 2019. PMID: 31068928 Free PMC article.
-
Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.Infect Immun. 2011 Mar;79(3):1289-99. doi: 10.1128/IAI.01139-10. Epub 2010 Dec 13. Infect Immun. 2011. PMID: 21149583 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources